Have a feature idea you'd love to see implemented?
Let us know!
ENFN Enfusion Inc
Price (delayed)
$10.1
Market cap
$1.3B
P/E Ratio
252.5
Dividend/share
N/A
EPS
$0.04
Enterprise value
$1.27B
Enfusion Inc. offers software-as-a-service for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time
Highlights
Enfusion's equity has increased by 38% YoY and by 9% from the previous quarter
Enfusion's revenue has increased by 16% YoY and by 3.6% QoQ
The EPS has shrunk by 50% YoY
The company's net income fell by 44% YoY and by 11% QoQ
Key stats
What are the main financial stats of ENFN
Market
Valuations
Earnings
Shares outstanding
128.57M
Market cap
$1.3B
Enterprise value
$1.27B
Price to earnings (P/E)
252.5
Price to book (P/B)
18.55
Price to sales (P/S)
4.81
EV/EBIT
306.21
EV/EBITDA
54.38
EV/Sales
6.51
Revenue
$195.16M
EBIT
$4.15M
EBITDA
$23.38M
Free cash flow
$21.07M
Per share
Balance sheet
Liquidity
EPS
$0.04
Free cash flow per share
$0.23
Book value per share
$0.54
Revenue per share
$2.1
TBVPS
$1.45
Total assets
$134.94M
Total liabilities
$38.76M
Debt
$21.13M
Equity
$69.92M
Working capital
$61.87M
Debt to equity
0.3
Current ratio
3.62
Quick ratio
3.41
Net debt/EBITDA
-1.16
Margins
Efficiency
Dividend
EBITDA margin
12%
Gross margin
67.2%
Net margin
1.7%
Operating margin
3.4%
Return on assets
2.8%
Return on equity
5.4%
Return on invested capital
5.3%
Return on capital employed
3.7%
Return on sales
2.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ENFN stock price
How has the Enfusion stock price performed over time
Intraday
2.12%
1 week
2.23%
1 month
11.23%
1 year
1.81%
YTD
4.12%
QTD
6.43%
Financial performance
How have Enfusion's revenue and profit performed over time
Revenue
$195.16M
Gross profit
$131.06M
Operating income
$6.71M
Net income
$3.33M
Gross margin
67.2%
Net margin
1.7%
The net margin has dropped by 51% year-on-year and by 15% since the previous quarter
Enfusion's operating margin has decreased by 48% YoY
The company's net income fell by 44% YoY and by 11% QoQ
Enfusion's operating income has decreased by 40% YoY but it has increased by 4.6% QoQ
Growth
What is Enfusion's growth rate over time
Valuation
What is Enfusion stock price valuation
P/E
252.5
P/B
18.55
P/S
4.81
EV/EBIT
306.21
EV/EBITDA
54.38
EV/Sales
6.51
The EPS has shrunk by 50% YoY
The price to earnings (P/E) is 13% higher than the last 4 quarters average of 224.3
Enfusion's equity has increased by 38% YoY and by 9% from the previous quarter
The P/B is 4.9% less than the last 4 quarters average of 19.5
Enfusion's revenue has increased by 16% YoY and by 3.6% QoQ
ENFN's price to sales (P/S) is 7% higher than its last 4 quarters average of 4.5
Efficiency
How efficient is Enfusion business performance
The company's return on invested capital has shrunk by 51% YoY
The ROS fell by 49% YoY
ENFN's ROE is down by 48% YoY and by 18% from the previous quarter
ENFN's ROA is down by 47% year-on-year and by 18% since the previous quarter
Dividends
What is ENFN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ENFN.
Financial health
How did Enfusion financials performed over time
Enfusion's total liabilities has increased by 36% YoY and by 26% QoQ
Enfusion's total assets has increased by 33% YoY and by 12% from the previous quarter
The debt is 70% smaller than the equity
Enfusion's equity has increased by 38% YoY and by 9% from the previous quarter
The debt is up by 28% year-on-year and by 17% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.